91 related articles for article (PubMed ID: 25844806)
1. Flexible lab-tailored cut-offs for suitability of formalin-fixed tumor samples for diagnostic mutational analyses.
Mariani S; Di Bello C; Bonello L; Tondat F; Pacchioni D; Molinaro L; Barreca A; Macrì L; Chiusa L; di Celle PF; Cassoni P; Sapino A
PLoS One; 2015; 10(4):e0121815. PubMed ID: 25844806
[TBL] [Abstract][Full Text] [Related]
2. A rapid and sensitive enzymatic method for epidermal growth factor receptor mutation screening.
Jänne PA; Borras AM; Kuang Y; Rogers AM; Joshi VA; Liyanage H; Lindeman N; Lee JC; Halmos B; Maher EA; Distel RJ; Meyerson M; Johnson BE
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):751-8. PubMed ID: 16467085
[TBL] [Abstract][Full Text] [Related]
3. Multi-center evaluation of the novel fully-automated PCR-based Idylla™ BRAF Mutation Test on formalin-fixed paraffin-embedded tissue of malignant melanoma.
Melchior L; Grauslund M; Bellosillo B; Montagut C; Torres E; Moragón E; Micalessi I; Frans J; Noten V; Bourgain C; Vriesema R; van der Geize R; Cokelaere K; Vercooren N; Crul K; Rüdiger T; Buchmüller D; Reijans M; Jans C
Exp Mol Pathol; 2015 Dec; 99(3):485-91. PubMed ID: 26407762
[TBL] [Abstract][Full Text] [Related]
4. Extended RAS and BRAF Mutation Analysis Using Next-Generation Sequencing.
Sakai K; Tsurutani J; Yamanaka T; Yoneshige A; Ito A; Togashi Y; De Velasco MA; Terashima M; Fujita Y; Tomida S; Tamura T; Nakagawa K; Nishio K
PLoS One; 2015; 10(5):e0121891. PubMed ID: 25954997
[TBL] [Abstract][Full Text] [Related]
5. High-resolution melting analysis as a sensitive prescreening diagnostic tool to detect KRAS , BRAF , PIK3CA , and AKT1 mutations in formalin-fixed, paraffin-embedded tissues.
Ney JT; Froehner S; Roesler A; Buettner R; Merkelbach-Bruse S
Arch Pathol Lab Med; 2012 Sep; 136(9):983-92. PubMed ID: 22938585
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of BRAF mutation testing methodologies in formalin-fixed, paraffin-embedded cutaneous melanomas.
Lade-Keller J; Rømer KM; Guldberg P; Riber-Hansen R; Hansen LL; Steiniche T; Hager H; Kristensen LS
J Mol Diagn; 2013 Jan; 15(1):70-80. PubMed ID: 23159593
[TBL] [Abstract][Full Text] [Related]
7. BRAFV600E detection in melanoma is highly improved by COLD-PCR.
Pinzani P; Santucci C; Mancini I; Simi L; Salvianti F; Pratesi N; Massi D; De Giorgi V; Pazzagli M; Orlando C
Clin Chim Acta; 2011 May; 412(11-12):901-5. PubMed ID: 21262211
[TBL] [Abstract][Full Text] [Related]
8. Pyrosequencing method to detect KRAS mutation in formalin-fixed and paraffin-embedded tumor tissues.
Dufort S; Richard MJ; de Fraipont F
Anal Biochem; 2009 Aug; 391(2):166-8. PubMed ID: 19464247
[TBL] [Abstract][Full Text] [Related]
9. Development of pyrosequencing methods for the rapid detection of RAS mutations in clinical samples.
Cortes U; Guilloteau K; Rouvreau M; Archaimbault C; Villalva C; Karayan-Tapon L
Exp Mol Pathol; 2015 Oct; 99(2):207-11. PubMed ID: 26163758
[TBL] [Abstract][Full Text] [Related]
10. Rapid targeted somatic mutation analysis of solid tumors in routine clinical diagnostics.
Magliacane G; Grassini G; Bartocci P; Francaviglia I; Dal Cin E; Barbieri G; Arrigoni G; Pecciarini L; Doglioni C; Cangi MG
Oncotarget; 2015 Oct; 6(31):30592-603. PubMed ID: 26435479
[TBL] [Abstract][Full Text] [Related]
11. Competitive allele specific TaqMan PCR for KRAS, BRAF and EGFR mutation detection in clinical formalin fixed paraffin embedded samples.
Didelot A; Le Corre D; Luscan A; Cazes A; Pallier K; Emile JF; Laurent-Puig P; Blons H
Exp Mol Pathol; 2012 Jun; 92(3):275-80. PubMed ID: 22426079
[TBL] [Abstract][Full Text] [Related]
12. Droplet Digital PCR for Mutation Detection in Formalin-Fixed, Paraffin-Embedded Melanoma Tissues: A Comparison with Sanger Sequencing and Pyrosequencing.
McEvoy AC; Wood BA; Ardakani NM; Pereira MR; Pearce R; Cowell L; Robinson C; Grieu-Iacopetta F; Spicer AJ; Amanuel B; Ziman M; Gray ES
J Mol Diagn; 2018 Mar; 20(2):240-252. PubMed ID: 29305225
[TBL] [Abstract][Full Text] [Related]
13. Development of a rapid and practical mutation screening assay for human lung adenocarcinoma.
Choi H; Kratz J; Pham P; Lee S; Ray R; Kwon YW; Mao JH; Kang HC; Jablons D; Kim IJ
Int J Oncol; 2012 Jun; 40(6):1900-6. PubMed ID: 22407457
[TBL] [Abstract][Full Text] [Related]
14. BRAF mutation testing with a rapid, fully integrated molecular diagnostics system.
Janku F; Claes B; Huang HJ; Falchook GS; Devogelaere B; Kockx M; Bempt IV; Reijans M; Naing A; Fu S; Piha-Paul SA; Hong DS; Holley VR; Tsimberidou AM; Stepanek VM; Patel SP; Kopetz ES; Subbiah V; Wheler JJ; Zinner RG; Karp DD; Luthra R; Roy-Chowdhuri S; Sablon E; Meric-Bernstam F; Maertens G; Kurzrock R
Oncotarget; 2015 Sep; 6(29):26886-94. PubMed ID: 26330075
[TBL] [Abstract][Full Text] [Related]
15. Molecular and Immunohistochemical Characterization of Historical Long-Term Preserved Fixed Tissues from Different Human Organs.
Hühns M; Röpenack P; Erbersdobler A
PLoS One; 2015; 10(8):e0135297. PubMed ID: 26252375
[TBL] [Abstract][Full Text] [Related]
16. Accurate detection of BRAF p.V600E mutations in challenging melanoma specimens requires stringent immunohistochemistry scoring criteria or sensitive molecular assays.
Fisher KE; Cohen C; Siddiqui MT; Palma JF; Lipford EH; Longshore JW
Hum Pathol; 2014 Nov; 45(11):2281-93. PubMed ID: 25228337
[TBL] [Abstract][Full Text] [Related]
17. Multicenter Evaluation of a Novel Automated Rapid Detection System of BRAF Status in Formalin-Fixed, Paraffin-Embedded Tissues.
Schiefer AI; Parlow L; Gabler L; Mesteri I; Koperek O; von Deimling A; Streubel B; Preusser M; Lehmann A; Kellner U; Pauwels P; Lambin S; Dietel M; Hummel M; Klauschen F; Birner P; Möbs M
J Mol Diagn; 2016 May; 18(3):370-377. PubMed ID: 26921540
[TBL] [Abstract][Full Text] [Related]
18. [Screening for EGFR mutations in lung cancer by a novel real-time PCR with double-loop probe and Sanger DNA sequencing].
Zhang HP; Ruan L; Zheng LM; Bai DY; Zhang HF; Liao YQ; Ding Y
Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):28-32. PubMed ID: 23648296
[TBL] [Abstract][Full Text] [Related]
19. Variation in pre-PCR processing of FFPE samples leads to discrepancies in BRAF and EGFR mutation detection: a diagnostic RING trial.
Kapp JR; Diss T; Spicer J; Gandy M; Schrijver I; Jennings LJ; Li MM; Tsongalis GJ; de Castro DG; Bridge JA; Wallace A; Deignan JL; Hing S; Butler R; Verghese E; Latham GJ; Hamoudi RA
J Clin Pathol; 2015 Feb; 68(2):111-8. PubMed ID: 25430497
[TBL] [Abstract][Full Text] [Related]
20. A novel mutant-enriched liquidchip technology for the qualitative detection of somatic mutations in KRAS gene from both serum and tissue samples.
Wu S; Zhu Z; He J; Luo X; Xu J; Ren-Heidenreich L
Clin Chem Lab Med; 2010 Aug; 48(8):1103-6. PubMed ID: 20482381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]